AMEinfo EXPERTS
by John Peacock
BSA Ahmad Bin Hezeem & Associates


VIEW ALL EXPERTS

GSK probing claims of improper conduct in Iraq

April 8, 2014 2:44 am


GlaxoSmithKline (GSK) has said it is investigating allegations of improper conduct in Iraq, nine months after China began a corruption probe into the local operations of the UK’s largest drugmaker, Bloomberg has reported. “These allegations relate to a small number of individuals,” the London-based company said. “However, we are investigating whether there has been any improper conduct. We have zero tolerance for unethical or illegal behaviour.” In Iraq, Glaxo hired 16 government-employed doctors and pharmacists as paid sales representatives, the Wall Street Journal reported, citing e-mails from an unidentified person familiar with Glaxo’s Mideast operations. Glaxo’s pharmaceutical operations employ fewer than 60 people in Iraq, according to the company.

By

AMEinfo EXPERTS
by Marco Saviozzi
GMG brokers


by Ismail Al Hammadi
Al Ruwad Real Estate


VIEW ALL EXPERTS